Bolt Biotherapeutics names Sheila Gujrathi chief strategy officer
BOLT•Bolt Biotherapeutics named Sheila Gujrathi chief strategy officer and a board member following its acquisition of Prana Therapies. Gujrathi co-founded Prana and formerly served as its CEO.
1. Leadership appointment
Bolt Biotherapeutics named Sheila Gujrathi chief strategy officer and a board member following its acquisition of Prana Therapies. Gujrathi is Prana’s co-founder and former chief executive officer.
